Drug intelligence / Profile preview

VIVIO Junior

Development stage: Unknown
Lead developer: Scope Health
Modality: Small Molecules
Administration: Oral

Overview

VIVIO Junior is an oral multivitamin liquid tonic developed by Scope Health, specifically designed for children aged one year and older. Formerly marketed as Vivioptal Junior, the formulation includes 12 essential vitamins along with increased levels of Zinc and added Iodine. It is indicated for pediatric nutritional supplementation and the prevention of general childhood vitamin deficiencies. The supplement supports normal growth and development, immune system function, and cognitive performance, while also contributing to the maintenance of normal bones and the reduction of tiredness and fatigue. As a consumer healthcare product, it is available over-the-counter to support the nutritional needs of growing children.

Brand names: VIVIO JuniorVivioptal Junior
Other names: VIVIO Junior multivitamins

Beyond the preview

Go deeper on VIVIO Junior.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIVIO Junior.

Explore the full profile